Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
(Q)SAR
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
results derived from a valid (Q)SAR model and falling into its applicability domain, with adequate and reliable documentation / justification
Justification for type of information:
QSAR prediction

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2020
Report date:
2020

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
other: REACH guidance on QSARs
Principles of method if other than guideline:
ACD/Percepta (Advanced Chemistry Development, Inc., Pharma Algorithms, Inc.) (release 2018.2.5)
GLP compliance:
no
Test type:
other: QSAR

Test material

1
Chemical structure
Reference substance name:
(S)-3-(tert-butylamino)propane-1,2-diol
EC Number:
250-125-1
EC Name:
(S)-3-(tert-butylamino)propane-1,2-diol
Cas Number:
30315-46-9
Molecular formula:
C7H17NO2
IUPAC Name:
3-(tert-butylamino)propane-1,2-diol
Test material form:
solid: particulate/powder
Specific details on test material used for the study:
Smile: CC(C)(C)NC[C@H](O)CO

Test animals

Species:
rat

Administration / exposure

Route of administration:
oral: unspecified

Results and discussion

Effect levels
Sex:
not specified
Dose descriptor:
LD50
Effect level:
2 900 mg/kg bw
Based on:
test mat.

Applicant's summary and conclusion

Interpretation of results:
Category 5 based on GHS criteria
Conclusions:
Acute oral LD50 in rat equal to 2900 mg/kg (non toxic, no classification is required).

The target compound 1-tert-Butylamino-2,3-propanediol, (S)- is included in the model applicability domain since the RI is greater than 0.3 (RI equal to 0.31). Borderline reliable.